ANAVEON AG hat dies direkt geteilt
Next in our BioLeaders interview series is Andreas Katopodis. Andreas is the Co-founder and CEO of ANAVEON AG, he also has 26 years of previous experience at Novartis and Ciba-Geigy. Anaveon is a global clinical stage biopharmaceutical company that specialises in developing novel treatments for diseases with high unmet needs. Read the interview on our website to learn more about Andreas’ personal and professional journey and his views on challenges facing the life science industry: https://lnkd.in/gP7xuh74 #LifeScience #BioPharma #Leadership